217 related articles for article (PubMed ID: 24788876)
1. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus.
Chang YC; Olson J; Louie A; Crocker PR; Varki A; Nizet V
J Mol Med (Berl); 2014 Sep; 92(9):951-9. PubMed ID: 24788876
[TBL] [Abstract][Full Text] [Related]
2. Sialic Acid-Siglec-E Interactions Regulate the Response of Neonatal Macrophages to Group B Streptococcus.
Lund SJ; Del Rosario PGB; Honda A; Caoili KJ; Hoeksema MA; Nizet V; Patras KA; Prince LS
Immunohorizons; 2024 May; 8(5):384-396. PubMed ID: 38809232
[TBL] [Abstract][Full Text] [Related]
3. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
Chang YC; Olson J; Beasley FC; Tung C; Zhang J; Crocker PR; Varki A; Nizet V
PLoS Pathog; 2014 Jan; 10(1):e1003846. PubMed ID: 24391502
[TBL] [Abstract][Full Text] [Related]
4. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
[TBL] [Abstract][Full Text] [Related]
5. Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169).
Bradford BM; Crocker PR; Mabbott NA
Immunology; 2014 Sep; 143(1):120-9. PubMed ID: 24684244
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
[TBL] [Abstract][Full Text] [Related]
7. Dual actions of group B
Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
[TBL] [Abstract][Full Text] [Related]
8. A Siglec-1-like lectin from Nile tilapia (Oreochromis niloticus) possesses functions of agglutination and mediation of macrophage phagocytic activity.
Kong L; Wu L; Guo Z; Mu L; Yang Y; Bian X; Li B; Pan X; Fu S; Ye J
Fish Shellfish Immunol; 2020 Jul; 102():203-210. PubMed ID: 32330627
[TBL] [Abstract][Full Text] [Related]
9. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
10. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
Jones C; Virji M; Crocker PR
Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
[TBL] [Abstract][Full Text] [Related]
11. Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.
Heikema AP; Koning RI; Duarte dos Santos Rico S; Rempel H; Jacobs BC; Endtz HP; van Wamel WJ; Samsom JN
Infect Immun; 2013 Jun; 81(6):2095-103. PubMed ID: 23529622
[TBL] [Abstract][Full Text] [Related]
12. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
[TBL] [Abstract][Full Text] [Related]
13. The interplay between Siglecs and sialylated pathogens.
Chang YC; Nizet V
Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
[TBL] [Abstract][Full Text] [Related]
14. Distinct Group B
Flaherty RA; Aronoff DM; Gaddy JA; Petroff MG; Manning SD
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558317
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
[TBL] [Abstract][Full Text] [Related]
16. A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
Saito M; Yamamoto S; Ozaki K; Tomioka Y; Suyama H; Morimatsu M; Nishijima KI; Yoshida SI; Ono E
Microb Pathog; 2016 Oct; 99():106-110. PubMed ID: 27544323
[TBL] [Abstract][Full Text] [Related]
17. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
Carlin AF; Chang YC; Areschoug T; Lindahl G; Hurtado-Ziola N; King CC; Varki A; Nizet V
J Exp Med; 2009 Aug; 206(8):1691-9. PubMed ID: 19596804
[TBL] [Abstract][Full Text] [Related]
18. Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni.
Klaas M; Oetke C; Lewis LE; Erwig LP; Heikema AP; Easton A; Willison HJ; Crocker PR
J Immunol; 2012 Sep; 189(5):2414-22. PubMed ID: 22851711
[TBL] [Abstract][Full Text] [Related]
19. Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.
Chattopadhyay D; Carey AJ; Caliot E; Webb RI; Layton JR; Wang Y; Bohnsack JF; Adderson EE; Ulett GC
Microbes Infect; 2011 Apr; 13(4):369-382. PubMed ID: 21238599
[TBL] [Abstract][Full Text] [Related]
20. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]